Studies estimate that 10-20 percent of men with #prostatecancer will develop #CRPC. Be sure to talk to your doctor to learn more about disease progression.pic.twitter.com/EMdJIRREhg

19:04 EDT 22 Sep 2018 | Pfizer

Studies estimate that 10-20 percent of men with #prostatecancer will develop #CRPC. Be sure to talk to your doctor to learn more about disease progression. pic.twitter.com/EMdJIRREhg

More From BioPortfolio on "Studies estimate that 10-20 percent of men with #prostatecancer will develop #CRPC. Be sure to talk to your doctor to learn more about disease progression.pic.twitter.com/EMdJIRREhg"